Calcium Chloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Calcium Chloride Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 11/07/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-4928-34
- Dosage Form
- Injection
- Presentation
- Calcium Chloride, Injection, 100 mg/1 mL (NDC 0409-4928-34)
- Initial Posting
- 11/07/2025
- Revised Date